Class 4 Caution in use-Clobazam suspension 5mg/5ml & 10mg/5ml

Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.

MHRA drug alert date: 13th December 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-clobazam-atnahs-5mg-slash-5ml-and-10mg-slash-5ml-oral-suspension-el-23-a-slash-43?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d9cfeb7b-3172-4a81-9b19-60e910ea91a1&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For more information, or medical information queries, please contact +44 (0) 1268 943 700, and for stock control queries, please contact +44 (0) 1268 943 700.